ENTITY
Giant Biogene

Giant Biogene (2367 HK)

81
Analysis
Consumer StaplesChina
Giant Biogene Holding Co., Ltd researches, develops, manufactures, and distributes, and markets skin treatment products. The Company produces recombinant collagen and rare ginsenosides skin treatment products, functional foods, and other products. Giant Biogene Holding conducts businesses in China.
more
Refresh
bullishGiant Biogene
21 Jun 2024 09:06

Giant Biogene (2367.HK) Placement - A Turning Point in Performance Growth Has Emerged

Based on the data from Tiktok channel, GMV of Comfy/Collagen was RMB190/396 million (+62%/+674% YoY respectively) from May 24 to Jun.18 (the 618...

Logo
713 Views
Share
bullishGiant Biogene
16 May 2024 18:55

Giant Biogene Placement - Has Been Doing Well but Doesn’t Need the Cash

Giant Biogene (2367 HK) aims to raise up to US$205m via a top-up placement. In this note, we talk about the deal dynamics and run the deal through...

Logo
254 Views
Share
bullishGiant Biogene
23 Nov 2023 16:22

2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher

Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.

Logo
444 Views
Share
bearishGiant Biogene
02 May 2023 09:57

Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x

Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...

Logo
361 Views
Share
bullishL'Occitane
09 Aug 2023 14:05

L’Occitane (973 HK): HK$35 Offer from the Controlling Shareholder?

Shares are currently in a trading halt. The rumoured offer price of HK$35 per share is attractive and represents an all-time high price. Therefore,...

Logo
410 Views
Share
x